Clarity Pharmaceuticals Ltd (ASX:CU6)

Clarity Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	47.68	47.9	31.21	55.34	8.44
Short-Term Investments	36.43	88.6	33.8	37	10.5
Cash & Short-Term Investments	84.12	136.51	65.01	92.34	18.94
Cash Growth	-38.38%	109.96%	-29.59%	387.54%	202.28%
Other Receivables	10.1	12.63	10	6.66	3.37
Receivables	10.1	12.63	10	6.66	3.37
Prepaid Expenses	6.33	4.83	1.66	0.56	0.2
Other Current Assets	0.06	0.09	-	-	-
Total Current Assets	100.61	154.06	76.68	99.55	22.51
Property, Plant & Equipment	0.55	0.55	0.21	0.26	0.09
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01
Total Assets	101.17	154.63	76.9	99.82	22.61
Accounts Payable	3.21	2.08	2.85	2.85	0.23
Accrued Expenses	4.36	2.7	1.84	4.16	1.18
Current Income Taxes Payable	-	0.21	-	-	-
Current Unearned Revenue	-	-	-	-	0.08
Other Current Liabilities	2.82	3.09	2.85	0.49	0.76
Total Current Liabilities	10.38	8.09	7.54	7.51	2.25
Other Long-Term Liabilities	0.56	0.24	0.18	0.08	0.08
Total Liabilities	10.94	8.33	7.72	7.59	2.34
Common Stock	268.94	262.4	132.82	132.12	44.9
Retained Earnings	-176.99	-112.7	-70.37	-45.8	-28.85
Comprehensive Income & Other	-1.71	-3.4	6.73	5.92	4.22
Shareholders' Equity	90.23	146.3	69.18	92.24	20.28
Total Liabilities & Equity	101.17	154.63	76.9	99.82	22.61
Net Cash (Debt)	84.12	136.51	65.01	92.34	18.94
Net Cash Growth	-38.38%	109.96%	-29.59%	387.54%	202.28%
Net Cash Per Share	0.26	0.50	0.25	0.37	0.11
Filing Date Shares Outstanding	321.47	311.65	260.66	257.94	190.42
Total Common Shares Outstanding	321.47	311.65	260.66	257.94	189.82
Working Capital	90.23	145.97	69.14	92.04	20.26
Book Value Per Share	0.28	0.47	0.27	0.36	0.11
Tangible Book Value	90.23	146.3	69.18	92.24	20.28
Tangible Book Value Per Share	0.28	0.47	0.27	0.36	0.11
Machinery	1.1	0.93	0.44	0.39	0.18

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.